Skip to main content
OpenTrials
Completed

NCT Number: NCT04236154

"Prescribing" Exercise to Cancer Patients At High-Risk for Falls

Falls are common and catastrophic in cancer patients. Cancer patients are vulnerable to falls due to muscle loss. In prescribing exercise in a data driven manner to cancer patients, our hypothesis is this "prescription" for exercise will eventually be demonstrated to reduce the occurrence of injurious falls.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 1

Primary location

Mayo Clinic

Rochester, Minnesota, 55905, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Any cancer diagnosis, as documented in medical record, other than non-melanoma skin cancer.
  • No issues such as unstable angina or loss of a limb that would preclude exercise.

Exclusion criteria

  • Diagnosis of non-melanoma skin cancer
  • Unstable angina
  • Loss of limb, which limits exercise capabilities at the discretion of the Principal Investigators
  • Pregnant women

Treatment and study plan

Pedometer

Other

Participants will wear a pedometer for 4 days at baseline, and 4-6 weeks later. Baseline readings will be used to derive an individualized exercise program for each participant based on the assigned experimental arm.

Actigraph

Other

Participants will wear a Actigraph for 4 days at baseline and 4-6 weeks later. Baseline readings will be used to derive an individualized exercise program for each participant based on the assigned experimental arm.

Perturbation Treadmill

Other

Participants will walk on an instrumented treadmill while wearing a safety harness at baseline and 4-6 weeks later. The perturbation treadmill will assess an individual's risk for falling. Baseline readings will be used to derive an individualized exercise program for each participant based on the assigned experimental arm.

Primary outcomes

  1. ABC Activities Specific Balance Confidence Scale (exploratory outcome)

    Time frame: Change from baseline ABC scale at 4-6 weeks

    Patient Reported Outcome 0% No confidence, 100% Complete Confidence, higher score= better outcome

Sponsors and collaborators

Lead sponsor

Mayo Clinic

Other

Collaborators

  • Andersen Foundation

Registry information

Important dates

Study start
2020
Primary completion
2024
Study completion
2024
First posted
Jan 22, 2020
Registry last updated
Oct 15, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.